A detailed history of Moseley Investment Management Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Moseley Investment Management Inc holds 7,763 shares of ABBV stock, worth $1.39 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares
7,763
Previous 7,641 1.6%
Holding current value
$1.39 Million
Previous $1.31 Million 17.02%
% of portfolio
0.63%
Previous 0.62%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$163.84 - $199.33 $19,988 - $24,318
122 Added 1.6%
7,763 $1.53 Million
Q2 2024

Jul 16, 2024

BUY
$154.79 - $180.76 $10,525 - $12,291
68 Added 0.9%
7,641 $1.31 Million
Q1 2024

Apr 04, 2024

BUY
$159.82 - $182.1 $11,347 - $12,929
71 Added 0.95%
7,573 $1.38 Million
Q4 2023

Jan 25, 2024

SELL
$137.6 - $154.97 $625,667 - $704,648
-4,547 Reduced 37.74%
7,502 $1.16 Million
Q3 2023

Oct 16, 2023

SELL
$133.59 - $154.65 $19,637 - $22,733
-147 Reduced 1.21%
12,049 $1.8 Million
Q2 2023

Jul 06, 2023

BUY
$132.51 - $164.9 $111,705 - $139,010
843 Added 7.43%
12,196 $1.64 Million
Q1 2023

May 03, 2023

BUY
$144.61 - $166.54 $44,829 - $51,627
310 Added 2.81%
11,353 $1.81 Million
Q4 2022

Jan 24, 2023

SELL
$138.31 - $165.87 $6,362 - $7,630
-46 Reduced 0.41%
11,043 $0
Q3 2022

Oct 13, 2022

BUY
$134.21 - $153.93 $125,352 - $143,770
934 Added 9.2%
11,089 $1.49 Million
Q2 2022

Jul 15, 2022

BUY
$137.62 - $174.96 $45,139 - $57,386
328 Added 3.34%
10,155 $1.56 Million
Q1 2022

Apr 21, 2022

SELL
$131.98 - $163.75 $36,954 - $45,850
-280 Reduced 2.77%
9,827 $1.59 Million
Q4 2021

Jan 25, 2022

BUY
$107.43 - $135.93 $11,387 - $14,408
106 Added 1.06%
10,107 $1.37 Million
Q3 2021

Oct 27, 2021

BUY
$106.4 - $120.78 $65,329 - $74,158
614 Added 6.54%
10,001 $1.09 Million
Q2 2021

Aug 11, 2021

BUY
$105.21 - $117.21 $59,969 - $66,809
570 Added 6.46%
9,387 $1.06 Million
Q1 2021

Apr 19, 2021

SELL
$102.3 - $112.62 $1,534 - $1,689
-15 Reduced 0.17%
8,817 $954,000
Q4 2020

Jan 26, 2021

BUY
$80.49 - $108.67 $77,672 - $104,866
965 Added 12.27%
8,832 $946,000
Q3 2020

Nov 04, 2020

SELL
$85.91 - $100.83 $31,700 - $37,206
-369 Reduced 4.48%
7,867 $689,000
Q2 2020

Jul 24, 2020

BUY
$73.37 - $98.18 $61,850 - $82,765
843 Added 11.4%
8,236 $809,000
Q1 2020

Apr 20, 2020

SELL
$64.5 - $97.79 $4,837 - $7,334
-75 Reduced 1.0%
7,393 $563,000
Q4 2019

Jan 15, 2020

SELL
$72.13 - $90.25 $109,926 - $137,541
-1,524 Reduced 16.95%
7,468 $661,000
Q3 2019

Oct 30, 2019

SELL
$62.98 - $75.72 $112,104 - $134,781
-1,780 Reduced 16.52%
8,992 $681,000
Q2 2019

Jul 16, 2019

BUY
$65.7 - $83.98 $205,115 - $262,185
3,122 Added 40.81%
10,772 $783,000
Q1 2019

May 09, 2019

BUY
$77.14 - $90.79 $590,121 - $694,543
7,650 New
7,650 $617,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $317B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Moseley Investment Management Inc Portfolio

Follow Moseley Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moseley Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Moseley Investment Management Inc with notifications on news.